Literature DB >> 8244502

Nerve conduction studies and its importance in diagnosis of acute poliomyelitis.

M Agboatwalla1, S R Kirmani, A Sonawalla, D S Akram.   

Abstract

Motor nerve conduction velocities was performed on 50 subjects in the pediatric age group. Thirty two patients with acute poliomyelitis and 18 controls. The MNCV was studied in the median nerve in the upper limb and the posterior tibial in the lower limb. The motor nerve conduction velocity in polio patients matched well with the controls, as well as within the accepted standards for normal. The MNCV of the median nerve ranged from 41.8 +/- 2.76 m/sec in under 1 year to 44 +/- 2.1 m/sec in 3-8 years, in polio patients, while the range in controls varied from 37 to 53 m/sec. Similarly, for the posterior tibial nerve, in polio patients the value of MNCV varied from 38.7 +/- 4.9 m/sec to 42.5 +/- 3.1 m/sec. In the controls, also the MNCV ranged from 38.5 +/- 6.3 m/sec to 48.4 +/- 3.42 m/sec. Thus, no delay on the motor nerve conduction velocity was seen. Poliomyelitis is a major problem in developing countries like Pakistan and India, where serological diagnosis is a luxury. The determination of motor nerve conduction velocity provides a quick and easy method of distinguishing poliomyelitis from other motor nerve disorders esp. Guillain Barre syndrome.

Entities:  

Mesh:

Year:  1993        PMID: 8244502     DOI: 10.1007/bf02822188

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  3 in total

1.  Motor nerve conduction velocity studies in poliomyelitis.

Authors:  E W JOHNSON; J D GUYTON; K J OLSEN
Journal:  Arch Phys Med Rehabil       Date:  1960-05       Impact factor: 3.966

2.  The electrical activity of single motor units in human poliomyelitis.

Authors:  R HODES
Journal:  Fed Proc       Date:  1947

3.  Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union.

Authors:  V P Grachev
Journal:  Rev Infect Dis       Date:  1984 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.